21/04/2017 13:17:08

Notice on the convened ordinary general meeting of shareholders of AB Klaipėdos Nafta

We hereby inform you that on the initiative and by the decision of the Board of AB Klaipėdos nafta code 110648893, registered at Burių st. 19, Klaipėda (hereinafter, the “Company”), an ordinary general meeting of shareholders of the Company was convened on 21 April 2017 at 13:00 p.m. The meeting was held in the registered office of the Company at Burių st.19, Klaipėda.

Agenda of the meeting:

1. On the announcement of the Auditor’s Report regarding the Financial Statements and Annual Report of the Company for the year 2016 to the shareholders

2. On the announcement of the Annual Report of AB Klaipėdos nafta for the year 2016 to the shareholders.

3. On the approval of the audited Financial Statements of AB Klaipedos nafta for the year 2016.

4. On the appropriation of profit (loss) of AB Klaipėdos nafta for the year 2016.

5. On the assignment of the audit company that shall perform the audit of the Financial Statements for the year 2017 and 2018 and the approval of the terms of payment for audit services.

6. On the approval of the decision of Company’s board to sign loan agreement with Nordic Investment Bank.

Decisions adopted:

1. On the announcement of the Auditor’s Report regarding the Financial Statements and Annual Report of the Company for the year 2016 to the shareholders:

The Auditor’s Report regarding the Financial Statements and Annual Report of the Company for the year 2016 had been heard by the shareholders. Decision on this topic of the Agenda should not be taken.”

2. On the announcement of the Annual Report of AB Klaipėdos nafta for the year 2016 to the shareholders:

The Annual Report of  AB Klaipėdos nafta for the year 2016, as drafted by the Company, assessed by the Auditor and approved by the Board of AB Klaipėdos nafta had been heard. Decision on this topic of the Agenda should not be taken.”

3. On the approval of the audited Financial Statements of AB Klaipedos nafta for the year 2016:

“To approve the audited Financial Statements of AB Klaipėdos nafta for the year 2016.”

4. On the appropriation of profit (loss) of AB Klaipėdos nafta for the year 2016:

“To distribute the Company’s profit in the total sum of  EUR 13,794,308 available for appropriation, as follows:

 

No.

Ratios

Amount, Euro

1

Non-allocated profit (loss) at the beginning of the financial year as of 01-01-2016

                        -   

2

Net profit (loss) for the financial year

      13.794.308,18   

3

Transfers from restricted reserves

                        -   

4

Shareholders' contribution against losses

                        -   

5

Portion of the reserve of tangible fixed assets

                        -   

6

Profit for allocation (1+2+3+4+5)

      13.794.308,18   

7

Allocation of earnings to legal reserve

          689.715,41 

8

Allocation of profit to own shares acquisition

                        -   

9

Allocation of profit to other reserves

       3.448.577,04   

10

Allocation of profit to dividends

       9.656.015,73   

11

Allocation of profit to tantiems

                        -   

12

Non-allocated profit (loss) at the end of the year 2016 carried forward to next financial year (6-7-8-9-10-11)

                        -   

 

5. On the assignment of the audit company that shall perform the audit of the Financial Statements for the year 2017 and 2018 and the approval of the terms of payment for audit services:

“1. Based on the results of the Public Tender “Purchase of Financial Statement and Regulated Activities Statements  Audit Services for the Years 2017 and 2018” the audit company to be assigned for the performance of the audit of the Financial Statements and Regulated Activities Statements of the Company and assessment of its Annual Report for the years 2017 and 2018, shall be UAB “Ernst & Young Baltic”, (hereinafter – the Auditor);

2. To authorize the General Manger of the Company to conclude the contract for audit services, based on which the total audit fee in the amount of EUR 48,000.00 exclusive of VAT shall be paid for the audit of the Company’s Financial Statement and Regulated Activity Statement, assessment of the Annual Report for the years 2017 and 2018 and drafting of the Auditor’s Report (hereinafter – the Audit Fee), as well as to determine the following conditions of payment:

The Auditor shall issue invoices for the Audit fee, as follows:

a) Invoice in amount of 20% Audit fee shall be issued after the performance of the intermediary audit of the year 2017.

b) Invoice in amount of 20% Audit fee shall be issued after the Auditor presents to the Company the report on the Company’s financial statements for the year 2017. 

c) Invoice in amount of 10% Audit fee shall be issued after the Auditor presents to the Company the Auditor’s report on the Company’s regulated activity statements for the year 2017. 

d) Invoice in amount of 20% Audit fee shall be issued after the performance of the intermediary audit of the year 2018.

e) Invoice in amount of 20% Audit fee shall be issued after the Auditor presents to the Company the report on the Company’s financial statements for the year 2018. 

f) Invoice in amount of 10% Audit fee shall be issued after the Auditor presents to the Company the Auditor’s report on the Company’s regulated activity statements for the year 2018.

The Company shall pay the invoices within 30 days as of receipt of the invoices.

6. On the approval of the decision of Company’s board to sign loan agreement with Nordic Investment Bank:

“To approve the decision of AB Klaipedos Nafta Board:

1. Sign loan agreement with Nordic Investment bank (hereinafter – NIB), where:

1.1 maximum amount of the loan would be EUR 20 700 000 (twenty million seven hundred thousand) euros;

1.2 the loan amount should be repaid in the latter half of the year 2031;

1.3 interest: floating interest rate (margin of 1,20% adding 6 month Euribor);

2. To authorize the General Manager of AB “Klaipedos Nafta” to decide on borrowing conditions, including, but not limited to decide due to requested disbursement amount and repayment conditions.”

         Marius Pulkauninkas, Director of Finance and Administration Department, +370 46 391 763.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
14 Aug
PNDORA
  Jeg har løbende adgang til Carnegies analyser af Pandora og har senest i dag modtaget seks slides,..
55
18 Aug
VWS
Normal 0 false false false DA X-NONE X-NONE ..
32
16 Aug
BAVA
Kære Bavarian aktionærer jeg har forsøgt at samle lidt informationer sammen dels taget fra ”sodazare..
23
17 Aug
 
Hvis du ikke kan tåle -1,5% uden at skulle skrive et indlæg om at gå kontant, er aktiemarkedet for h..
21
15 Aug
VWS
Hej Per.   1) Når et selskab køber aktier bliver de en del af virksomhedens ejendom - de kan derfor ..
15
15 Aug
VWS
Stop nu dig selv menneske. Du har tudet og vrælet op om, hvor elendigt kursen har ageret siden oktob..
14
16 Aug
NOVO-B
Jeg synes lige at I skal læse disse kloge ord:   For those of you who watch what you eat. Here’s the..
13
19 Aug
BAVA
For pokker det bliver interessant hvad de har af opdateringer. Vi ved de har lovet opdatering på Pro..
12
17 Aug
VWS
Jamen Herregud da. Er det et svaghedstegn, at Vestas performer i henhold til deres egen guidence?   ..
12
17 Aug
VWS
Der er tale om en forskydning af indtjenningen mellem 2 og 3 kvt. 2017 i forhold til 2016. 3. kvt. b..
12

Form 8.5 (EPT/RI) - Tesco plc

21/08/2017 07:43:02
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant se..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

18/08/2017 15:36:47
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Prima BioMed Appoints Non-Executive Director to the Board
2
Gamers Get First Chance to Play Xbox One X at GameStop Expo
3
Saniona AB: Saniona's partner, Medix, initiates Phase 3 study for tesofensine in obesity
4
Cecilie B. Heuch appointed EVP and Chief People Officer of Telenor Group
5
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 August 2017 13:10:49
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170808.1 - EUROWEB2 - 2017-08-21 14:10:49 - 2017-08-21 13:10:49 - 1000 - Website: OKAY